Dividend Delight: Pharma Stock Declares 18% Dividend, Q4 Profit | How To Get Eligible For Payout?

Dividend Alert: BSE Healthcare stock, Lincoln Pharmaceuticals Limited, will remain in focus during Friday's trading session after the healthcare company announced 18% dividend for financial year 2025-26. The company had also announced its fourth quarter result for FY 26.

Lincoln Pharmaceuticals share price closed 1.76% higher at Rs 758.35 per share on BSE with a market capitalisation of Rs 1,518.95 crore on Wednesday, May 27. The stock had touched an intraday high of Rs 770 per share and an intraday low of Rs 737.50 per share.

Lincoln Pharmaceuticals Dividend

The healthcare company's board of directors had recommended an 18% dividend for eligible investors for FY 26. The board had "recommended a dividend of 18% (i.e Rs 1.80/- per share) per equity share of face value of 10/· for the year ended March 31, 2026, for approval of the members at the ensuring annual general meeting (AGM) of the Company," read a BSE filing released by Lincoln Pharmaceuticals on Thursday, May 28.

Lincoln Pharmaceuticals Q4 Result

The company had reported a net profit of Rs 11.63 crore for the fourth quarter of the financial year 2025-26 against Rs 11.57 crore reported in the year-ago period. The company's revenue from operations stood at Rs 183.08 crore in Q4FY26 against Rs 161.39 crore in Q4FY25. Lincoln Pharmaceuticals' net revenue jumped close to 13.5% on an annual basis.

Lincoln Pharmaceuticals Dividend: How To Get Eligible?

To become eligible for the payout, it is important for investors to own the company stock onr or before the dividend record date. The company is yet to fix the dividend record date.

Lincoln Pharmaceuticals Share PRice Trend

The stock closed in green on Wednesday. The pharmaceutical stock had touched its 52-week high mark of Rs 770 per share on May 27, 2026. The stock dipped to its 52-week low mark of Rs 439.95 per share on January 28, 2026. The stock has a return on equity (ROE) of 13.74%. It has delivered close to 58% return year to date (YTD) and 100% returns in three years.